Duopharma Biotech Berhad (KLSE:DPHARMA)
1.500
+0.020 (1.35%)
At close: Mar 6, 2026
Duopharma Biotech Berhad Market Cap
Duopharma Biotech Berhad has a market cap or net worth of 1.34 billion as of March 9, 2026. Its market cap has increased by 12.10% in one year.
Market Cap
1.34B
Enterprise Value
1.54B
Revenue
931.69M
Ranking
n/a
PE Ratio
15.29
Stock Price
1.50
Market Cap Chart
Since August 27, 2002, Duopharma Biotech Berhad's market cap has increased from 187.00M to 1.34B, an increase of 615.03%. That is a compound annual growth rate of 8.71%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DXN Holdings Bhd. | 2.46B |
| Kotra Industries Berhad | 605.12M |
| Y.S.P. Southeast Asia Holding Berhad | 295.04M |
| Sunzen Group Berhad | 190.02M |
| Rhone Ma Holdings Berhad | 157.74M |
| Nova Wellness Group Berhad | 122.71M |
| PeterLabs Holdings Berhad | 72.93M |
| Bioalpha Holdings Berhad | 21.10M |